Literature DB >> 30139025

[Incidence and mortality of nasopharyngeal carcinoma in China, 2014].

Z T Fu1, X L Guo1, S W Zhang2, H M Zeng2, K X Sun2, W Q Chen2, J He3.   

Abstract

Objective: To estimate the incidence and mortality of nasopharyngeal carcinoma in China based on cancer registration data in 2014, collected by the National Central Cancer Registry (NCCR).
Methods: 449 cancer registries submitted nasopharyngeal carcinoma incidence and deaths occurred in 2014 to NCCR. After evaluating the data quality, 339 registries' data were accepted for analysis and stratified by area (urban/rural) and age group. Combined with data on national population in 2014, the nationwide incidence and mortality of nasopharyngeal carcinoma were estimated. Chinese population census in 2000 and Segi's population were used for age-standardized incidence and mortality rates.
Results: The estimates of new nasopharyngeal carcinoma incident cases and deaths were 44.6 thousands and 24.2 thousands, respectively. The crude incidence rate was 3.26/100 000 (Male 4.51/100 000, Female 1.94/100 000). Age-standardized incidence rates by Chinese standard population (ASIRC, 2000) and by world standard population (ASIRW) were 2.48/100 000 and 2.33/100 000, respectively. Male to female ratio was 2.32∶1. The ASIRC in urban and rural areas were all 2.48/100 000. The crude mortality rate of nasopharyngeal carcinoma was 1.77/100 000 (Male 2.55/100 000, Female 0.95/100 000). Age-standardized mortality rates by Chinese standard population (ASMRC, 2000) and by world standard population(ASMRW) were 1.23/100 000 and 1.20/100 000, respectively. The ASMRC in urban and rural areas were all 1.23/100 000. The cumulative incidence and mortality rates(0-74 years old)were 0.25% and 0.14%, respectively. Conclusions: Incidence and mortality of nasopharyngeal carcinoma in China in 2014 were at high levels in the world. Corresponding prevention and control measures should be established according to the epidemic characteristics and risk factors of nasopharyngeal carcinoma.

Entities:  

Keywords:  China; Incidence; Mortality; Nasopharyngeal neoplasms; Neoplasms registration

Mesh:

Year:  2018        PMID: 30139025     DOI: 10.3760/cma.j.issn.0253-3766.2018.08.002

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  11 in total

1.  Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin in the first-line setting for Chinese patients with metastatic nasopharyngeal carcinoma.

Authors:  Chaohui Jin; Hanrui Zheng; Mei Zhan; Feng Wen; Ting Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-12       Impact factor: 2.503

2.  Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.

Authors:  Junying Guo; Zhaolei Cui; Yuhong Zheng; Xiaoli Li; Yan Chen
Journal:  Pathol Oncol Res       Date:  2020-03-28       Impact factor: 3.201

3.  SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.

Authors:  Xin Nie; Ergang Guo; Cheng Wu; Dongbo Liu; Wei Sun; Linli Zhang; Guoxian Long; Qi Mei; Kongming Wu; Huihua Xiong; Guoqing Hu
Journal:  Cancer Med       Date:  2019-03-24       Impact factor: 4.452

4.  ER resident protein 44 promotes malignant phenotype in nasopharyngeal carcinoma through the interaction with ATP citrate lyase.

Authors:  Hui Tian; Si Shi; Bo You; Qicheng Zhang; Miao Gu; Yiwen You
Journal:  J Transl Med       Date:  2021-02-16       Impact factor: 5.531

5.  A Nomogram Based on Circulating CD4+ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.

Authors:  De-Song Shen; Chang Yan; Kai-Hua Chen; Ling Li; Song Qu; Xiao-Dong Zhu
Journal:  J Inflamm Res       Date:  2021-12-09

6.  Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.

Authors:  De-Song Shen; Chang Yan; Yu Liang; Kai-Hua Chen; Xiao-Dong Zhu
Journal:  Cancer Manag Res       Date:  2021-10-27       Impact factor: 3.989

7.  Isolated Sixth Nerve Palsy as a First Presentation of Nasopharyngeal Carcinoma: A Case Series.

Authors:  Apatsa Lekskul; Supanat Thanomteeranant; Phantaraporn Tangtammaruk; Wadakarn Wuthisiri
Journal:  Int Med Case Rep J       Date:  2021-11-23

8.  Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis.

Authors:  Zhishan Wu; Haojia Wang; Jiarui Wu; Siyu Guo; Wei Zhou; Chao Wu; Shan Lu; Miaomiao Wang; Xiaomeng Zhang; Jialin Li; Yingying Tan; Xiaotian Fan; Zhihong Huang
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

9.  Expression of miR-34a and Ki67 in nasopharyngeal carcinoma and the relationship with clinicopathological features and prognosis.

Authors:  Linqi Wei; Chao Shi; Yonghong Zhang
Journal:  Oncol Lett       Date:  2019-12-13       Impact factor: 2.967

10.  Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.

Authors:  Lili Chang; Lina Zhang; Haiquan Jia; Zhiyong Nie; Lei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.